| Authors: |
Harlow CE; GSK, Gunnels Wood Road, Stevenage, UK. charli.e.harlow@gsk.com., Uzochukwu E; UK Dementia Research Institute, Department of Psychological Medicine and Clinical Neuroscience, University of Cardiff, Cardiff, UK., Fernando HA; GSK, Gunnels Wood Road, Stevenage, UK.; Leeds Institute of Data Analytics, University of Leeds, Leeds, UK., Mordaunt CE; GSK, Upper Providence, PA, USA., Hughey JM; GSK, Upper Providence, PA, USA., Eicher JD; GSK, Cambridge, MA, USA., Robinson L; Nuffield Department of Clinical Neuroscience, Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, Sherrington Road, University of Oxford, Oxford, UK., Bowker N; GSK, Gunnels Wood Road, Stevenage, UK., Howe L; GSK, Gunnels Wood Road, Stevenage, UK., Liu J; GSK, Upper Providence, PA, USA., Cortes A; GSK, Heidelberg, Germany., Wilson P; GSK, Gunnels Wood Road, Stevenage, UK., Gungabissoon U; GSK, Oxford Street, London, UK., Benson VS; GSK, Gunnels Wood Road, Stevenage, UK., Nash A; Nuffield Department of Clinical Neuroscience, Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, Sherrington Road, University of Oxford, Oxford, UK., Young G; GSK, Upper Providence, PA, USA., Addis L; GSK, Gunnels Wood Road, Stevenage, UK., Xu CF; GSK, Gunnels Wood Road, Stevenage, UK., Webber C; UK Dementia Research Institute, Department of Psychological Medicine and Clinical Neuroscience, University of Cardiff, Cardiff, UK., Davitte J; GSK, Upper Providence, PA, USA. jonathan.m.davitte@gsk.com., Cader MZ; Nuffield Department of Clinical Neuroscience, Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, Sherrington Road, University of Oxford, Oxford, UK. zameel.cader@ndcn.ox.ac.uk. |